Unilabs Diagnostics K.S. (Czech Republic)

Unilabs Diagnostics k.s. is the Czech operating entity of the international Unilabs group and one of the leading private providers of laboratory diagnostic services in the Czech Republic. Its main business segment is comprehensive laboratory medicine, covering clinical biochemistry, haematology, immunology and allergology, immunochemistry, microbiology, medical genetics, pathology and related specialised disciplines. Through its laboratories in major Czech cities and an extensive network of more than 80 to 90 blood collection points and partner collection sites across the country, the company provides routine and specialised testing for hospitals, outpatient physicians, occupational health providers and self paying individuals. The portfolio includes routine blood and urine tests, highly specialised immunological and genetic examinations, microbiological cultivation and PCR analyses, pathology and cytology examinations as well as dedicated testing services for selected therapeutic areas; Unilabs also operates an online store for self payers, offering selected laboratory tests directly to the public. Geographically, Unilabs Diagnostics k.s. is focused on the Czech Republic but is fully integrated into the broader Unilabs network spanning multiple European countries and Latin America, which allows it to share know how, specialised assays and quality management systems on a group wide level. Key brands and assets include the Unilabs brand (previously known on the Czech market under the AeskuLab name), a dense network of laboratories and collection points, a client service centre, digital platforms for ordering tests and retrieving results, and certifications that underpin quality and reliability of results. Strategically, the company positions itself as a high quality, innovation oriented diagnostics partner for healthcare providers, combining rapid turnaround times with a broad test menu and strong customer support, and increasingly focusing on digitalisation, patient friendly access (including direct to consumer testing) and the expansion of specialised laboratory services in line with international Unilabs standards.